← Home
Throughline · October 22, 2026 · 37m

The dramatic race to discover Insulin

In the early 1920s, a handful of scientists raced to isolate and mass-produce insulin, the world's first peptide-based medicine. Throughline explores how this life-saving breakthrough emerged from intense collaboration, fierce rivalries, and the desperate need to save children dying of diabetes. Historian Alison Li and curator Grant Maltman trace the human story behind the cure, the ethical dilemmas over patenting and access, and the scientific legacy that paved the way for today's injectable peptide industry. The episode connects the historic quest for insulin to today's obsession with peptide injectables used for weight loss and muscle building.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Preview

•
Insulin as the first peptide medicine
The 1920s race to isolate and mass-produce insulin established the fundamental techniques for extracting, purifying, and injecting protein-based drugs.
•
The messy human side of scientific discovery
The insulin discovery was marked by intense collaboration, fierce competition, and bitter disputes over credit among a small group of researchers.

1 more ideas, 1 references & all timestamps

This episode is in its early-access window. The full breakdown unlocks free in about 71 hours — Pro members read everything the moment it lands.

Read it now with Pro$10/mo · founding $96/yr
Was this useful?